- Home
- / SI-BONE
SI-BONE
Stock Price
$13.1
2024-10-29
Market Capitalization
$546.6 M
2024-10-29
Revenue
$200.9 M
FY, 2025
SI-BONE Summary
Company Summary
- Overview
- SI-BONE is a medical device company specializing in surgical solutions. It offers the iFuse Implant System for minimally invasive sacroiliac joint fusion surgery.
- Type
- Public
- Status
- Active
- Founded
- 2008
- HQ
- Santa Clara, CA, US | view all locations
- Website
- https://si-bone.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Laura Francis, CFO
Carlton Reckling, Chief Medical Officer
Daniel Cher, Vice President, Clinical Affairs
Operating MetricsView all
Patents Issued
40
Jun, 2018
Patents (US)
34
Jun, 2018
Patents Pending
18
Jun, 2018
LocationsView all
6 locations detected
Santa Clara, CA HQ
United States
471 El Camino Real #101
Santa Clara, CA
United States
2380 Owen St
Wettolsheim, Grand Est
France
6 Rue des Merisiers
Mannheim, BW
Germany
Steubenstraße 46
Gallarate, Lombardia
Italy
Vicolo Castello 6
Knaresborough, England
United Kingdom
Unit 7b, St James Business Park
SI-BONE Financials
Summary Financials
- Revenue (Q1, 2026)
- $52.6M
- Gross profit (Q1, 2026)
- $41.9M
- Net income (Q1, 2026)
- ($4.3M)
- Cash (Q1, 2026)
- $33.5M
- EBIT (Q1, 2026)
- ($5.1M)
- Enterprise value
- $556.0M